Russia New Coronavirus Vaccine
Search results: 39 photos

Employees work on the line of filling injectable drugs with a syringe-dose of the EpiVacCorona vaccine for the prevention of COVID-19 at the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5433x3548px, 14.5Mb
- Job-ID: 684bd4059d2def9b


General Director of the Vector enterprise of the State Scientific Center of Virology and Biotechnology Rinat Maksyutov stands near the line of filling injectable drugs with a syringe-dose of the EpiVacCorona vaccine for the prevention of COVID-19 at the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 4651x3294px, 10.1Mb
- Job-ID: bb5cc3060b9d8370


Employees work on the line of filling injectable drugs with a syringe-dose of the EpiVacCorona vaccine for the prevention of COVID-19 at the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5051x3114px, 10.6Mb
- Job-ID: a1543e485633be14


Employees work on the line of filling injectable drugs with a syringe-dose of the EpiVacCorona vaccine for the prevention of COVID-19 at the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 4892x3379px, 12.3Mb
- Job-ID: ed6188472339f001


Employees work on the line of filling injectable drugs with a syringe-dose of the EpiVacCorona vaccine for the prevention of COVID-19 at the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 4447x3104px, 10Mb
- Job-ID: 392d3de82bae944f


Employees work on the line of filling injectable drugs with a syringe-dose of the EpiVacCorona vaccine for the prevention of COVID-19 at the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 4295x2665px, 8.8Mb
- Job-ID: 409bc34a0aaf2018


Employees work on the line of filling injectable drugs with a syringe-dose of the EpiVacCorona vaccine for the prevention of COVID-19 at the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5195x3459px, 13.1Mb
- Job-ID: 8eace940bbd7053d


The view shows a package of new EpiVacCorona vaccine for the prevention of COVID-19 at the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5191x3394px, 13.7Mb
- Job-ID: 4060f20495c5bf34


The view shows the entrance to the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5568x3712px, 11Mb
- Job-ID: 9dde2b4658c44202


Employees talk to each other at the entrance to the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 4603x2784px, 8.8Mb
- Job-ID: 17df9664b4a76f8e


Employees stand at the entrance to the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 4932x3335px, 11.4Mb
- Job-ID: 6792d38e4134c3f2


An employee works at the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5368x3577px, 12Mb
- Job-ID: db244a7d2e5fac4b


General Director of the Vector enterprise of the State Scientific Center of Virology and Biotechnology Rinat Maksyutov stands at the entrance to the Scientific Center in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 3486x2337px, 5.4Mb
- Job-ID: fba738fd6cd9b2b8


General Director of the Vector enterprise of the State Scientific Center of Virology and Biotechnology Rinat Maksyutov is pictured at the Scientific Center in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5240x3050px, 8.6Mb
- Job-ID: 96638c08314dfd95


General Director of the Vector enterprise of the State Scientific Center of Virology and Biotechnology Rinat Maksyutov is pictured at the Scientific Center in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5186x3321px, 10.4Mb
- Job-ID: 514c3a82ae5dbf6e


Head of the Department of Zoonotic Infections and Influenza Alexander Ryzhikov is pictured at the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 4846x3178px, 9.9Mb
- Job-ID: 169d9e6b6b34314c


Head of the Department of Zoonotic Infections and Influenza Alexander Ryzhikov is pictured at the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5568x3712px, 13.5Mb
- Job-ID: 797384af0bcd27a2


Head of the Department of Zoonotic Infections and Influenza Alexander Ryzhikov is pictured at the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5182x3239px, 11.3Mb
- Job-ID: bd6380dd90c0c105


Mannequins, dressed in Personal Protective Equipment (PPE), stand at the entrance to the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 3671x2372px, 6.4Mb
- Job-ID: ce80fb9ff43a6a0b


Mannequins, dressed in Personal Protective Equipment (PPE), stand at the entrance to the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 4403x3033px, 8.8Mb
- Job-ID: b16f540a3cb1b1fb


The view shows the entrance to the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5473x3712px, 15.6Mb
- Job-ID: 387e56899642e27


Biohazard sign is seen on the entrance door to the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 2380x1754px, 3.1Mb
- Job-ID: ecfc693a76326971


A mannequin, dressed in a Personal Protective Equipment (PPE), stands at the entrance to the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 4941x3182px, 11.1Mb
- Job-ID: 193d54e93085828d


Deputy General Director for Scientific Work Elena Gavrilova straightens ьannequin's Personal Protective Equipment (PPE) at the entrance to the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5100x3339px, 10.9Mb
- Job-ID: db0830211f4c87ee


Deputy General Director for Scientific Work Elena Gavrilova stands at the entrance to the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5283x3296px, 11.4Mb
- Job-ID: 9e9fff19d784f46


An employee works at the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5414x3407px, 10.9Mb
- Job-ID: ed72cada85ba11e


An employee works at the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 4473x2723px, 7.7Mb
- Job-ID: b4fb1623f847632f


An employee works at the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 3444x2099px, 4.4Mb
- Job-ID: dd3fcb1e260ba810


An employee works at the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 4838x3026px, 9.4Mb
- Job-ID: f8b9ccb955febbcd


An employee works at the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5313x3495px, 13.3Mb
- Job-ID: a7baf23d9b4d0081


An employee works at the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 4959x3302px, 9.7Mb
- Job-ID: 84a781147fe3797


An employee works at the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5037x3461px, 9.9Mb
- Job-ID: 945e0c5fe23d7cb3


Employees work at the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5140x3373px, 10.8Mb
- Job-ID: b4af66b68fcc063b


An employee works at the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 3486x2756px, 9.4Mb
- Job-ID: 3c73dac5569fc87b


An employee is pictured with a background of a billboard in the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 4197x2858px, 7.5Mb
- Job-ID: a3cc718acc779bf7


An employee works at the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5113x3347px, 12.2Mb
- Job-ID: 61ffb57ab3086eb7


An employee works at the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 3629x2316px, 7.6Mb
- Job-ID: b0320d81be5151e9


An employee works at the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 5113x3351px, 11.1Mb
- Job-ID: bb8d6a7dbcbd3e6d


The view shows the entrance to the laboratory of the Vector enterprise of the State Scientific Center of Virology and Biotechnology in Novosibirsk, Russia. The State Scientific Center of Virology and Biotechnology "Vector" has developed new EpiVacCorona vaccine registered in Russia for the prevention of COVID-19.
- Package: Russia New Coronavirus Vaccine
- Categories: Health, Science & Technology
- Location: Novosibirsk, Russia
- Event date: 04.03.2021
- Date published: 11.03.2021
- Author: Grigory Sysoev
- Source: Sputnik
- Credit: Sputnik
- Original: Digital
- Media: JPEG, 3807x2550px, 6.5Mb
- Job-ID: 9fc8ab0dd46348e